InsidersTradesSigma
Track the 뉴로핏 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 뉴로핏 has published 2 public disclosures. Market capitalisation: €89bn. The latest transaction was disclosed on 30 April 2026 (Purchase). Among the most active insiders: 김창일. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Neurofit 是一家在 XKRX 市场上市的医疗保健和制药领域的公司。它专注于开发创新解决方案以改善患者健康。